Analyst Ratings for Myriad Genetics Inc. (MYGN)

Updated: 2017-07-26

An average rating of Hold has been given to Myriad Genetics Inc. (NASDAQ:MYGN) by analysts covering the stock. MYGN had previously received a consensus rating of Hold a month ago.

15 analysts issued ratings on the stock, where 2 gave MYGN a buy rating, 0 issued an overweight rating, 9 gave a hold rating, 1 gave an underweight rating, and 3 gave a sell rating. Today, there are 0 more analysts optimistic about the company future as compared with 90 days ago. Meanwhile, the number of analysts pessimistic about the company has increased by 0.

Investment analysts gave a few price targets for MYGN. The highest price target was 30, implying a possible profit of 26.37 percent. The minimum price target given was 16, which equates to a potential downside of -32.6 percent. One must be careful with overanalyzing price targets and ratings due to possible conflicts of interest among the analysts releasing them.

Analysts have revised their earnings estimates upwards for this quarter, by about 0 percent on average, compared to last month. This can be compared with the average change in earnings estimates over the past 3 months, which is -1.65 percent. Over the past 30 days, FY earnings estimates have also changed upwards by 0 percent. Expanding the time horizon to 3 months, the average change in fiscal year estimates becomes 3.56 percent.

People are often interested in whether analysts were united in the direction of their revisions. 0 analysts have revised their quarterly estimates upwards in the past 30 days, while 0 analysts made negative revisions. During this time, 2 analysts made positive revisions in their estimates for this fiscal year's earnings, while 0 analysts decreased their estimates.

The growth rate of MYGN's earnings is estimated by analysts to be 135.64 percent. It's possible to gain additional insight about growth valuation of a company by looking at the PEG ratio. Investors like to see smaller values for the PEG ratio, as that can indicate whether the high price level of a stock is warranted by high growth. Wall Street investors typically prefer a PEG ratio to be smaller than 1, although it is frequently more appropriate to compare PEG ratios to the company's peers. MYGN has a PEG ratio of 0.39.

In the trailing 52-weeks, MYGN hit 32.54 at the highest peak, while it's lowest trading point was 15.15. Today's price is 56.7 percent above the 52-week low, and 27.04 percent below the high. MYGN has a P/E ratio of 52.76. Investors typically compare the P/E ratio to a company's peers in the industry. The MYGN value stock report compares MYGN to some of its peers using value stock charts. The stock has a market capitalization of $1.63 billion. MYGN's next earnings release will be on 0000-00-00, which is days away.